Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Boswellia vs Vitamin D3: Vitamin D3 has the stronger overall evidence (7.5 vs 7.5/10); they're alternatives for pms relief — the best pick depends on your goals. Take the 60-second quiz for a pick tailored to your goals.
Vitamin D3 wins 1 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Probably helps
2 of 3 studies with measurable effects showed benefit.
Top outcomes
Verdict
Probably helps
7 of 14 studies with measurable effects showed benefit.
Top outcomes
Shared outcomes (1)
Outcomes where both Boswellia and Vitamin D3 have evidence — compare verdict strength side-by-side.
300-500mg standardized extract (30-40% AKBA), 2-3x daily (a typical label dose, not the dose used in the cited trials, the one that states its dose gave 100 mg a day of Aflapin, standardized to 20% AKBA)
With meals containing fat
Standardized extract (30-40% AKBA or 65% boswellic acids)
2000-4000 IU daily
Morning with breakfast
D3 (cholecalciferol) softgel or liquid
and 1 more not shown
4-8 weeks
4-8 weeks
2-4 weeks
4-8 weeks
4-8 weeks
2-4 weeks
4-8 weeks
Comparative Effectiveness of Nutritional Supplements in the Treatment of Knee Osteoarthritis: A Network Meta-Analysis
Nutrients (2025) · Meta analysis · n=4599
Bayesian rankings indicated Boswellia had the highest probability of being most effective for pain and stiffness, with krill oil and curcumin showing potential for function improvement.
Oral herbal medicines marketed in Brazil for the treatment of osteoarthritis: A systematic review and meta-analysis
Phytotherapy research : PTR (2017) · Meta analysis · n=1741
Z. officinale showed improvement of pain over placebo.
Oral herbal therapies for treating osteoarthritis
The Cochrane database of systematic reviews (2014) · Meta analysis · n=5980
Seventeen studies of confirmatory design (sample and effect sizes pre-specified) were mostly at moderate risk of bias.
Vitamin D supplementation vs. placebo and incident type 2 diabetes in an ancillary study of the randomized Vitamin D and Omega-3 Trial
Nature communications (2025) · Rct · n=22220
Ancillary analysis of VITAL: 22,220 adults without T2D randomized to vitamin D3 2000 IU/day or placebo, with a meta-analysis of 3 additional trials.
Vitamin D Supplementation for Patients with Dysmenorrhoea: A Meta-Analysis with Trial Sequential Analysis of Randomised Controlled Trials
Nutrients (2024) · Meta analysis · n=687
TSA revealed that the current RCTs provide sufficient information.
Vitamin D and respiratory tract infections
BMJ (2017) · Meta analysis · n=11321
25 RCTs, 11 321 participants aged 0 to 95 years. Vitamin D reduced acute respiratory tract infection overall (adjusted OR 0.88, 95% CI 0.81 to 0.96).
The Cochrane review of oral herbal therapies (PMID 24848732) found high-quality evidence from two trials (85 people) that 100 mg a day of an enriched Boswellia serrata extract for 90 days cut pain by 17 points on a 0 to 100 scale against placebo, with fewer adverse events than placebo in one trial. Effectiveness is that pain reduction. A 250 mg dose of enriched extract showed possible benefit in low-quality evidence from a single small study, so it is plotted flat, not higher. Trials of 100 mg Aflapin a day for 30 and 180 days also reduced knee pain against placebo (PMID 35512759, 39700461). A 999 mg dose of a non-enriched extract is a different product and is not plotted. The Cochrane authors state that the optimal daily dose is still to be determined.
Both points come from a meta-analysis of double-blind cholecalciferol trials in people aged 60 and over (PMID 15886381). Trials at 700 to 800 IU a day cut hip fracture risk by 26% (RR 0.74) and non-vertebral fractures by 23%, plotted at 800 IU. Trials at 400 IU a day showed no benefit (hip fracture RR 1.15), and the WHI trial of 400 IU with 1,000 mg calcium did not significantly reduce hip fracture (PMID 16481635). Most of these trials also gave calcium, and the Cochrane review found vitamin D alone unlikely to prevent fractures while vitamin D with calcium gave a small reduction (PMID 24729336). Doses above 800 IU were not compared, so no optimal dose or ceiling is set.
AI-estimated from published studies. Interpret as directional guidance.
Vitamin D3 has a higher evidence score (7.5/10 vs 7.5/10) and wins in 1 of 3 categories.
For pms relief, Vitamin D3 has a higher relevance score (78 vs 65).
No documented interaction was found in the data searched. This does not establish that this exact combination is safe.
Curcumin, omega-3, UC-II collagen, Boswellia vs the old glucosamine default — and OA vs RA.
The honest tier list — proven staples vs situational vs mostly marketing. The hub the other guides feed into.
On Ozempic/Wegovy/Mounjaro? What actually helps — muscle preservation, GI relief, nutrient gaps (no upsell).
Tired? Why most "energy" pills only work if they fix a deficit — and how to find yours first.
The right pick depends on your goals. Answer a few quick questions for a personalised recommendation — or dig into the full evidence on each.